| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Octreotide | FAERS: 5 | US FAERS | |
| 2 | Deferasirox | FAERS: 3 | OFFSIDES US FAERS | |
| 3 | Lamotrigine | FAERS: 3 | US FAERS | |
| 4 | Zoledronic Acid | FAERS: 3 | OFFSIDES US FAERS | |
| 5 | Ondansetron | FAERS: 2 | US FAERS | |
| 6 | adefovir dipivoxil | FAERS: 2 | US FAERS | |
| 7 | Furosemide | FAERS: 1 | US FAERS | |
| 8 | Omeprazole | FAERS: 1 | US FAERS | |
| 9 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 10 | Topiramate | FAERS: 1 | US FAERS | |
| 11 | apixaban | FAERS: 1 | US FAERS | |
| 12 | Nebivolol | OFFSIDES | ||
| 13 | Zonisamide | OFFSIDES | ||
| 14 | moxonidine | OFFSIDES | ||
| 15 | nilvadipine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.